These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9711591)

  • 1. Overexpression, purification, and function of first nucleotide-binding fold of cystic fibrosis transmembrane conductance regulator.
    Ko YH; Pedersen PL
    Methods Enzymol; 1998; 292():675-86. PubMed ID: 9711591
    [No Abstract]   [Full Text] [Related]  

  • 2. The cystic fibrosis transmembrane conductance regulator. Overexpression, purification, and characterization of wild type and delta F508 mutant forms of the first nucleotide binding fold in fusion with the maltose-binding protein.
    Ko YH; Thomas PJ; Delannoy MR; Pedersen PL
    J Biol Chem; 1993 Nov; 268(32):24330-8. PubMed ID: 7693699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis transmembrane conductance regulator: the first nucleotide binding fold targets the membrane with retention of its ATP binding function.
    Ko YH; Delannoy M; Pedersen PL
    Biochemistry; 1997 Apr; 36(16):5053-64. PubMed ID: 9125527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant synthesis of cystic fibrosis transmembrane conductance regulator and functional nucleotide-binding domains.
    King SA; Sorscher EJ
    Methods Enzymol; 1998; 292():686-97. PubMed ID: 9711592
    [No Abstract]   [Full Text] [Related]  

  • 5. Cloning and expression of DNA binding domains using PCR.
    Fox DG; Kneale GG
    Methods Mol Biol; 1994; 30():169-84. PubMed ID: 8004193
    [No Abstract]   [Full Text] [Related]  

  • 6. Fusions to maltose-binding protein: control of folding and solubility in protein purification.
    Sachdev D; Chirgwin JM
    Methods Enzymol; 2000; 326():312-21. PubMed ID: 11036650
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression and purification of the first nucleotide-binding domain and linker region of human multidrug resistance gene product: comparison of fusions to glutathione S-transferase, thioredoxin and maltose-binding protein.
    Wang C; Castro AF; Wilkes DM; Altenberg GA
    Biochem J; 1999 Feb; 338 ( Pt 1)(Pt 1):77-81. PubMed ID: 9931301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the cystic fibrosis transmembrane conductance regulator folding pathway.
    Qu BH; Thomas PJ
    J Biol Chem; 1996 Mar; 271(13):7261-4. PubMed ID: 8631737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous expression of the metal-binding domains of human copper-transporting ATPases (P1-ATPases).
    Lutsenko S; Petrukhin K; Gilliam TC; Kaplan JH
    Ann N Y Acad Sci; 1997 Nov; 834():155-7. PubMed ID: 9405803
    [No Abstract]   [Full Text] [Related]  

  • 10. A novel model for the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator.
    Annereau JP; Wulbrand U; Vankeerberghen A; Cuppens H; Bontems F; Tümmler B; Cassiman JJ; Stoven V
    FEBS Lett; 1997 May; 407(3):303-8. PubMed ID: 9175873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant peptide model of the first nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator: comparison of wild-type and delta F508 mutant forms.
    Yike I; Ye J; Zhang Y; Manavalan P; Gerken TA; Dearborn DG
    Protein Sci; 1996 Jan; 5(1):89-97. PubMed ID: 8771200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vectors that facilitate the expression and purification of foreign peptides in Escherichia coli by fusion to maltose-binding protein.
    di Guan C; Li P; Riggs PD; Inouye H
    Gene; 1988 Jul; 67(1):21-30. PubMed ID: 2843437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level expression and deletion mutagenesis of human tryptophan hydroxylase.
    Yang XJ; Kaufman S
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6659-63. PubMed ID: 8022832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prokaryotic expression of proteoglycans.
    Murdoch AD; Iozzo RV
    Methods Mol Biol; 2001; 171():231-8. PubMed ID: 11450233
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of purified recombinant Bet v 1 with authentic N-terminus, cloned in fusion with maltose-binding protein.
    Spangfort MD; Ipsen H; Sparholt SH; Aasmul-Olsen S; Larsen MR; Mørtz E; Roepstorff P; Larsen JN
    Protein Expr Purif; 1996 Nov; 8(3):365-73. PubMed ID: 8936599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level expression of soluble protein in Escherichia coli using a His6-tag and maltose-binding-protein double-affinity fusion system.
    Pryor KD; Leiting B
    Protein Expr Purif; 1997 Aug; 10(3):309-19. PubMed ID: 9268677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of recombinant rat myo-inositol 1,4,5-trisphosphate 3-kinase B suggests a regulatory role for its N-terminus.
    Thomas S; Soriano S; d'Santos C; Banting G
    Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):713-6. PubMed ID: 8920971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-step purification and characterization of MBP (maltose binding protein)-DnaJ fusion protein and its utilization for structure-function analysis.
    Ishii Y; Sonezaki S; Iwasaki Y; Tauchi E; Shingu Y; Okita K; Ogawa HI; Kato Y; Kondo A
    J Biochem; 1998 Oct; 124(4):842-7. PubMed ID: 9756632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TOXCAT: a measure of transmembrane helix association in a biological membrane.
    Russ WP; Engelman DM
    Proc Natl Acad Sci U S A; 1999 Feb; 96(3):863-8. PubMed ID: 9927659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and kinetic analysis of pea (Pisum sativum L.) NADPH:protochlorophyllide oxidoreductase expressed as a fusion with maltose-binding protein in Escherichia coli.
    Martin GE; Timko MP; Wilks HM
    Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):139-45. PubMed ID: 9224639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.